Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) vs Tempus AI (TEM) Price & Performance

JPMorgan Nasdaq Equity Premium Income ETFTrade

Price performance (Past 24H)

Key statistics

JPMorgan Nasdaq Equity Premium Income ETF vs Tempus AI — how do they compare? JPMorgan Nasdaq Equity Premium Income ETF trades at $61.04 (market cap $44.49B), while Tempus AI trades at $70.32 (market cap $12.58B). The key difference: JPMorgan Nasdaq Equity Premium Income ETF is far larger — about 3.5× Tempus AI's market cap, and JPMorgan Nasdaq Equity Premium Income ETF is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold JPMorgan Nasdaq Equity Premium Income ETF for 65 Days and Tempus AI for 22 Days on average.

JEPQTEM
Market Cap
$44.49B$12.58B
Volume
5,681,7897,444,569
Sector
Income / Options OverlayBroad Market / Factor
52-Week High
$61.46$99.28
52-Week Low
$53.77$41.55
Typical Hold Time
65 Days22 Days
Enterprise Value
—$13.21B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ trades at $61.27, showing minimal daily movement with a 0.03% gain. The ETF maintains a bullish technical outlook with strong moving average support, though oscillators signal some near-term caution. Recent dividend distributions of $0.57-$0.70 demonstrate the fund's income generation capability, with financial media highlighting its 11% estimated yield and positioning for AI infrastructure growth.

The covered-call strategy provides downside protection but limits upside potential during strong bull markets. Institutional interest remains positive with recent acquisitions, though investors should note the variable nature of distributions and the trade-off between high current income and long-term capital appreciation.

Tempus AI

Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.

The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JEPQ
86% Buy14% Sell
Avg holding period · 65 Days
TEM
24% Buy76% Sell
Avg holding period · 22 Days

Top news

Latest headlines on both assets

About JPMorgan Nasdaq Equity Premium Income ETF

JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.

Read more on JEPQ →

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Read more on TEM →